bucladesine has been researched along with beraprost in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Horie, S; Ishii, H; Kazama, M; Kizaki, K; Uchiyama, H | 1 |
| Kainoh, M; Maruyama, I; Nakadate, T; Nishio, S | 1 |
| Murata, T; Nishio, S; Umetsu, T | 1 |
| Asai, Y; Imai-Sasaki, R; Kainoh, M; Nakadate, T; Ogawa, Y; Ohmori, E | 1 |
| Kawahara, Y; Koide, M; Nakayama, I; Tsuda, T; Yokoyama, M | 1 |
| Araki, S; Haneda, M; Kikkawa, R; Koya, D; Sugimoto, T; Togawa, M | 1 |
| Inada, H; Onaya, T; Shindo, H; Tawata, M | 1 |
| Haneda, M; Inoki, K; Kikkawa, R; Koya, D; Maeda, S; Nishio, T | 1 |
| Furukawa, K; Harata, S; Iwasaki, K; Motomura, S; Ohishi, H; Okada, A; Toh, S; Ueyama, K | 1 |
| Fujita, T; Itoh, Y; Koyama, T; Kubota, T; Oishi, R; Saeki, K; Sendo, T; Yano, T; Yuo, A | 1 |
| Yano, T | 1 |
1 review(s) available for bucladesine and beraprost
| Article | Year |
|---|---|
[Cellular and molecular mechanisms in drug-induced nephrotoxicity and its prevention].
Topics: Animals; Anti-Infective Agents; Apoptosis; Bucladesine; Caspase 3; Caspase 9; Contrast Media; Cyclic AMP Response Element-Binding Protein; Epoprostenol; Humans; Kidney Diseases; Kidney Tubules; Mice; Mitochondria; Oncogene Protein v-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species | 2013 |
11 other study(ies) available for bucladesine and beraprost
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cyclic AMP increases thrombomodulin expression on membrane surface of cultured human umbilical vein endothelial cells.
Topics: 1-Methyl-3-isobutylxanthine; Bucladesine; Cell Membrane; Cells, Cultured; Cyclic AMP; Endothelium, Vascular; Epoprostenol; Humans; Platelet Aggregation Inhibitors; Receptors, Cell Surface; Receptors, Thrombin; Tetradecanoylphorbol Acetate; Thrombin | 1990 |
Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level.
Topics: 1-Methyl-3-isobutylxanthine; Bucladesine; Cell Membrane; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Humans; In Vitro Techniques; Interleukin-1; Receptors, Cell Surface; Receptors, Thrombin; Tumor Necrosis Factor-alpha | 1991 |
Studies on the antiplatelet effect of the stable epoprostenol analogue beraprost sodium and its mechanism of action in rats.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Bucladesine; Calcimycin; Calcium; Calcium Radioisotopes; Cyclic AMP; Epoprostenol; In Vitro Techniques; Male; Malondialdehyde; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Thrombin; Thromboxane B2 | 1989 |
Inhibition by beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability.
Topics: Biological Transport; Bucladesine; Cell Membrane Permeability; Cells, Cultured; Chromium Radioisotopes; Cyclic AMP; Endothelium, Vascular; Epoprostenol; Fluorescein-5-isothiocyanate; Humans; Platelet Aggregation Inhibitors; Serum Albumin, Bovine; Thrombin; Umbilical Veins | 1995 |
Cyclic AMP elevating agents synergize with inflammatory cytokines to induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells.
Topics: Alprostadil; Amino Acid Oxidoreductases; Animals; Bucladesine; Cells, Cultured; Colforsin; Cyclic AMP; Cytokines; Drug Synergism; Enzyme Induction; Epoprostenol; Gene Expression; In Vitro Techniques; Interferon-gamma; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Rats; RNA, Messenger | 1995 |
Differential inhibition of mesangial MAP kinase cascade by cyclic nucleotides.
Topics: Adrenomedullin; Animals; Bucladesine; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Cyclic AMP; Cyclic GMP; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Epoprostenol; Glomerular Mesangium; Mitogen-Activated Protein Kinase Kinases; Nucleotides, Cyclic; Peptides; Phorbol 12,13-Dibutyrate; Protein Kinases; Rats; Signal Transduction | 1996 |
cAMP regulates nitric oxide production and ouabain sensitive Na+, K+-ATPase activity in SH-SY5Y human neuroblastoma cells.
Topics: Bucladesine; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Enzyme Inhibitors; Epoprostenol; Humans; Isoquinolines; Kinetics; Neuroblastoma; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Ouabain; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Tumor Cells, Cultured | 1998 |
Cyclic AMP inhibits stretch-induced overexpression of fibronectin in glomerular mesangial cells.
Topics: Animals; Blotting, Northern; Blotting, Western; Bucladesine; Carbazoles; Cyclic AMP; Enzyme Activation; Enzyme Inhibitors; Epoprostenol; Fibronectins; Gene Expression Regulation; Glomerular Mesangium; Indoles; Male; Mitogen-Activated Protein Kinases; Nuclear Proteins; Oligonucleotides; Protein Binding; Pyrroles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Mechanical; Transcription Factor AP-1 | 2002 |
Role of prostaglandin I2 in the gene expression induced by mechanical stress in spinal ligament cells derived from patients with ossification of the posterior longitudinal ligament.
Topics: Adenylyl Cyclase Inhibitors; Alkaline Phosphatase; Anti-Inflammatory Agents; Base Sequence; Bucladesine; Cytochrome P-450 Enzyme System; DNA, Complementary; Epoprostenol; Gene Expression; Humans; Intramolecular Oxidoreductases; Longitudinal Ligaments; Molecular Sequence Data; Ossification of Posterior Longitudinal Ligament; Receptors, Epoprostenol; Receptors, Prostaglandin; Receptors, Prostaglandin E; Reverse Transcriptase Polymerase Chain Reaction; Stress, Mechanical | 2003 |
A prostacyclin analog prevents radiocontrast nephropathy via phosphorylation of cyclic AMP response element binding protein.
Topics: Animals; Apoptosis; Bucladesine; Caspases; Cell Survival; Contrast Media; Cyclic AMP Response Element-Binding Protein; Enzyme Activation; Epoprostenol; Kidney; Kidney Diseases; LLC-PK1 Cells; Mice; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphotransferases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Swine; Triiodobenzoic Acids | 2005 |